Cefodizime (CAS 69739-16-8)
QUICK LINKS
Cefodizime is a third-generation cephalosporin antibiotic that functions as a bactericidal agent by inhibiting the synthesis of the bacterial cell wall. It achieves this by binding to penicillin-binding proteins, such as PBP-3, leading to the disruption of peptidoglycan cross-linking during cell wall synthesis. This ultimately results in the lysis and death of the bacterial cell. Cefodizime′s mode of action involves interfering with the transpeptidation and transglycosylation processes, which are essential for the structural integrity of the bacterial cell wall. By targeting these specific cellular processes, cefodizime effectively disrupts the growth and proliferation of susceptible bacteria. This mechanism of action makes cefodizime useful for studying bacterial cell wall synthesis and the development of potential strategies for combating antibiotic resistance.
Cefodizime (CAS 69739-16-8) References
- Cefodizime enhances phagocytosis and intracellular killing of Staphylococcus aureus but does not influence polymorphonuclear leukocytes response to fMLP stimulation. | Bialasiewicz, P., et al. 2000. Int J Immunopharmacol. 22: 557-66. PMID: 10785552
- Influence of enhancers on the absorption and on the pharmacokinetics of cefodizime using in-vitro and in-vivo models. | Mrestani, Y., et al. 2004. J Pharm Pharmacol. 56: 485-93. PMID: 15099444
- Cefodizime: the Japanese clinical experience. | Matsumoto, K. 1992. Infection. 20 Suppl 1: S31-5. PMID: 1526674
- Immunomodulating effects of cefodizime on Klebsiella pneumoniae-stimulated neutrophils. | Song, H., et al. 2004. Immunobiology. 209: 277-82. PMID: 15518339
- The pharmacokinetics of cefodizime in children. | Boccazzi, A., et al. 1990. J Antimicrob Chemother. 26 Suppl C: 83-7. PMID: 2074256
- Stimulatory effect of cefodizime on macrophage-mediated phagocytosis. | Oishi, K., et al. 1989. J Antibiot (Tokyo). 42: 989-92. PMID: 2737956
- Cefodizime in acute purulent exacerbations of chronic respiratory disease. | Maesen, FP., et al. 1988. J Antimicrob Chemother. 22: 229-35. PMID: 3182418
- Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration. | Dagrosa, EE., et al. 1987. Clin Ther. 10: 18-31. PMID: 3450392
- Cefodizime, an aminothiazolylcephalosporin. V. Synthesis and structure-activity relationships in the cefodizime series. | Blumbach, J., et al. 1987. J Antibiot (Tokyo). 40: 29-42. PMID: 3558116
- Cefodizime penetration into skin suction blister fluid following a single intravenous dose. | Schäfer-Korting, M., et al. 1986. Eur J Clin Pharmacol. 30: 295-8. PMID: 3732363
- Cefodizime, an aminothiazolylcephalosporin. I. In vitro activity. | Limbert, M., et al. 1984. J Antibiot (Tokyo). 37: 892-900. PMID: 6090373
- Cefodizime, an aminothiazolyl cephalosporin. IV. Influence on the immune system. | Limbert, M., et al. 1984. J Antibiot (Tokyo). 37: 1719-26. PMID: 6098573
- In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin. | Jones, RN., et al. 1981. Antimicrob Agents Chemother. 20: 760-8. PMID: 6275785
- Cefodizime: effects of sub-inhibitory concentrations on adhesiveness and bacterial morphology of Staphylococcus aureus and Escherichia coli: comparison with cefotaxime and ceftriaxone. | Braga, PC., et al. 1997. J Antimicrob Chemother. 39: 79-84. PMID: 9044031
- Pharmacokinetics of cefodizime in patients with various degrees of renal failure. | Loffreda, A., et al. 1999. Chemotherapy. 45: 1-7. PMID: 9876203
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Cefodizime, 100 mg | sc-491882 | 100 mg | $117.00 | |||
Cefodizime, 1 g | sc-491882A | 1 g | $490.00 |